SCHEMBL6442843

SCHEMBL6442843

[CH2]C(C(C)C)N(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5749962 0.74 KDM4E (0.33)
SCHEMBL244295 0.70
SCHEMBL26981421 0.70
Hydrochloric Acid SCHEMBL4849626 0.67
SCHEMBL10395750 0.65
SCHEMBL438330 0.61
SCHEMBL20586 0.59
SCHEMBL1193514 0.59
SCHEMBL10876137 0.59 ALDH1A1 (0.62)
SCHEMBL1290008 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050130941-A1 Methods of treating alzheimer's disease PHARMACIA & UPJOHN COMPANY LLC 2005-06-16 US disclosed
EP-1392315-A1 METHODS OF TREATING ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-03-03 EP disclosed
US-6645960-B1 Antiprotozoa agents for animal or human infections GLAXO WELLCOME S.A. (ES) 2003-11-11 US disclosed
EP-0830336-B1 PROCESS FOR THE PREPARATION OF TERTIARY AMINOCARBONATES AND AMINOETHERS CROMPTON CORP (US) 2003-05-21 EP disclosed
WO-2002100410-A1 METHODS OF TREATING ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed
EP-1228049-A1 ANTIFUNGAL SORDARICIN DERIVATIVES Glaxo Wellcome S.A. (ES) 2002-08-07 EP disclosed
WO-2001034583-A1 ANTIFUNGAL SORDARICIN DERIVATIVES GLAXO WELLCOME SA (ES) 2001-05-17 WO disclosed
CN-1054598-C Pharmacologically active hydrazine derivatives and processes for preparation thereof NORVATIS CO (CH) 2000-07-19 CN disclosed
US-5753652-A Antiretroviral hydrazine derivatives NOVARTIS CORPORATION (US) 1998-05-19 US disclosed
EP-0521827-B1 Pharmacological active hydrazin derivatives and process for their preparation CIBA GEIGY AG (CH) 1996-09-25 EP disclosed
CN-1068333-A Has hydrazine analog derivative of pharmacologically active and preparation method thereof CIBA GEIGY AG (CH) 1993-01-27 CN disclosed
EP-0521827-A1 Pharmacological active hydrazin derivatives and process for their preparation CIBA-GEIGY AG (CH) 1993-01-07 EP disclosed
US-4224315-A Pseudotrisaccharides and their medicinal use BAYER AKTIENGESELLSCHAFT (DE) 1980-09-23 US disclosed